Global AI Drug Discovery Software Supply, Demand and Key Producers, 2026-2032
The global AI Drug Discovery Software market size is expected to reach $ 2452 million by 2032, rising at a market growth of 15.4% CAGR during the forecast period (2026-2032).
AI drug discovery software is a software tool that accelerates the drug development process by utilizing artificial intelligence algorithms and technologies. This software integrates and analyzes a vast amount of bioinformatics data, chemical structure data, and clinical trial data to predict key properties such as compound bioactivity, pharmacokinetic characteristics, and toxicity. With the help of AI technology, drug researchers can more quickly and accurately screen potential candidate drugs, thereby reducing development costs, shortening development cycles, and improving success rates.
Upstream inputs include cloud computing infrastructure, GPUs and AI accelerators, chemical and biological databases, omics data, and experimental datasets generated by wet labs. Open-source AI frameworks and proprietary foundation models also form an important upstream layer. The midstream consists of AI drug discovery software vendors that develop platforms integrating algorithms, data management, molecular modeling, and workflow orchestration. Downstream customers are primarily pharmaceutical companies, biotechnology firms, and CROs, which use these tools either internally or through collaborative partnerships. Increasingly, AI software is embedded into broader R&D ecosystems rather than deployed as standalone tools.
Gross margins in the AI Drug Discovery Software market are generally high due to its software-centric and IP-driven nature. Pure software or SaaS-based platforms typically achieve gross margins of 65?85%, supported by subscription licensing and relatively low marginal distribution costs. However, margins can be diluted when vendors adopt hybrid models that include customized projects, data curation, or experimental validation support, where gross margins often fall to the 50?65% range. Compute-intensive workloads, particularly for large generative models, remain a key cost factor influencing margin sustainability.
This report studies the global AI Drug Discovery Software demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for AI Drug Discovery Software, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of AI Drug Discovery Software that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global AI Drug Discovery Software total market, 2021-2032, (USD Million)
Global AI Drug Discovery Software total market by region & country, CAGR, 2021-2032, (USD Million)
U.S. VS China: AI Drug Discovery Software total market, key domestic companies, and share, (USD Million)
Global AI Drug Discovery Software revenue by player, revenue and market share 2021-2026, (USD Million)
Global AI Drug Discovery Software total market by Type, CAGR, 2021-2032, (USD Million)
Global AI Drug Discovery Software total market by Application, CAGR, 2021-2032, (USD Million)
This report profiles major players in the global AI Drug Discovery Software market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Merck KGaA, Atomwise Inc, BenevolentAI, BullFrog AI, Genesis Therapeutics, Pharma.AI, Recursion Pharmaceuticals, Verge Genomics, Schr?dinger, Inc., XtalPi, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the world AI Drug Discovery Software market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.
Global AI Drug Discovery Software Market, By Region:
1. How big is the global AI Drug Discovery Software market?
2. What is the demand of the global AI Drug Discovery Software market?
3. What is the year over year growth of the global AI Drug Discovery Software market?
4. What is the total value of the global AI Drug Discovery Software market?
5. Who are the Major Players in the global AI Drug Discovery Software market?
6. What are the growth factors driving the market demand?
AI drug discovery software is a software tool that accelerates the drug development process by utilizing artificial intelligence algorithms and technologies. This software integrates and analyzes a vast amount of bioinformatics data, chemical structure data, and clinical trial data to predict key properties such as compound bioactivity, pharmacokinetic characteristics, and toxicity. With the help of AI technology, drug researchers can more quickly and accurately screen potential candidate drugs, thereby reducing development costs, shortening development cycles, and improving success rates.
Upstream inputs include cloud computing infrastructure, GPUs and AI accelerators, chemical and biological databases, omics data, and experimental datasets generated by wet labs. Open-source AI frameworks and proprietary foundation models also form an important upstream layer. The midstream consists of AI drug discovery software vendors that develop platforms integrating algorithms, data management, molecular modeling, and workflow orchestration. Downstream customers are primarily pharmaceutical companies, biotechnology firms, and CROs, which use these tools either internally or through collaborative partnerships. Increasingly, AI software is embedded into broader R&D ecosystems rather than deployed as standalone tools.
Gross margins in the AI Drug Discovery Software market are generally high due to its software-centric and IP-driven nature. Pure software or SaaS-based platforms typically achieve gross margins of 65?85%, supported by subscription licensing and relatively low marginal distribution costs. However, margins can be diluted when vendors adopt hybrid models that include customized projects, data curation, or experimental validation support, where gross margins often fall to the 50?65% range. Compute-intensive workloads, particularly for large generative models, remain a key cost factor influencing margin sustainability.
This report studies the global AI Drug Discovery Software demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for AI Drug Discovery Software, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of AI Drug Discovery Software that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global AI Drug Discovery Software total market, 2021-2032, (USD Million)
Global AI Drug Discovery Software total market by region & country, CAGR, 2021-2032, (USD Million)
U.S. VS China: AI Drug Discovery Software total market, key domestic companies, and share, (USD Million)
Global AI Drug Discovery Software revenue by player, revenue and market share 2021-2026, (USD Million)
Global AI Drug Discovery Software total market by Type, CAGR, 2021-2032, (USD Million)
Global AI Drug Discovery Software total market by Application, CAGR, 2021-2032, (USD Million)
This report profiles major players in the global AI Drug Discovery Software market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Merck KGaA, Atomwise Inc, BenevolentAI, BullFrog AI, Genesis Therapeutics, Pharma.AI, Recursion Pharmaceuticals, Verge Genomics, Schr?dinger, Inc., XtalPi, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the world AI Drug Discovery Software market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.
Global AI Drug Discovery Software Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Rest of World
- Cloud Based
- On Premise
- Target Identification & Validation
- Hit Discovery / Virtual Screening
- Lead Optimization
- ADMET & Toxicity Prediction
- Candidate Selection & Preclinical Support
- Molecular Property Prediction
- De Novo Molecule Generation
- Protein?Ligand Interaction Modeling
- Multi-Parameter Optimization
- Knowledge Graph?Based Discovery
- CRO and Universities
- Pharmaceutical Company
- Test Lab
- Merck KGaA
- Atomwise Inc
- BenevolentAI
- BullFrog AI
- Genesis Therapeutics
- Pharma.AI
- Recursion Pharmaceuticals
- Verge Genomics
- Schr?dinger, Inc.
- XtalPi
- Iktos
1. How big is the global AI Drug Discovery Software market?
2. What is the demand of the global AI Drug Discovery Software market?
3. What is the year over year growth of the global AI Drug Discovery Software market?
4. What is the total value of the global AI Drug Discovery Software market?
5. Who are the Major Players in the global AI Drug Discovery Software market?
6. What are the growth factors driving the market demand?
1 SUPPLY SUMMARY
1.1 AI Drug Discovery Software Introduction
1.2 World AI Drug Discovery Software Market Size & Forecast (2021 & 2025 & 2032)
1.3 World AI Drug Discovery Software Total Market by Region (by Headquarter Location)
1.3.1 World AI Drug Discovery Software Market Size by Region (2021-2032), (by Headquarter Location)
1.3.2 United States Based Company AI Drug Discovery Software Revenue (2021-2032)
1.3.3 China Based Company AI Drug Discovery Software Revenue (2021-2032)
1.3.4 Europe Based Company AI Drug Discovery Software Revenue (2021-2032)
1.3.5 Japan Based Company AI Drug Discovery Software Revenue (2021-2032)
1.3.6 South Korea Based Company AI Drug Discovery Software Revenue (2021-2032)
1.3.7 ASEAN Based Company AI Drug Discovery Software Revenue (2021-2032)
1.3.8 India Based Company AI Drug Discovery Software Revenue (2021-2032)
1.4 Market Drivers, Restraints and Trends
1.4.1 AI Drug Discovery Software Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Major Market Trends
2 DEMAND SUMMARY
2.1 World AI Drug Discovery Software Consumption Value (2021-2032)
2.2 World AI Drug Discovery Software Consumption Value by Region
2.2.1 World AI Drug Discovery Software Consumption Value by Region (2021-2026)
2.2.2 World AI Drug Discovery Software Consumption Value Forecast by Region (2027-2032)
2.3 United States AI Drug Discovery Software Consumption Value (2021-2032)
2.4 China AI Drug Discovery Software Consumption Value (2021-2032)
2.5 Europe AI Drug Discovery Software Consumption Value (2021-2032)
2.6 Japan AI Drug Discovery Software Consumption Value (2021-2032)
2.7 South Korea AI Drug Discovery Software Consumption Value (2021-2032)
2.8 ASEAN AI Drug Discovery Software Consumption Value (2021-2032)
2.9 India AI Drug Discovery Software Consumption Value (2021-2032)
3 WORLD AI DRUG DISCOVERY SOFTWARE COMPANIES COMPETITIVE ANALYSIS
3.1 World AI Drug Discovery Software Revenue by Player (2021-2026)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global AI Drug Discovery Software Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for AI Drug Discovery Software in 2025
3.2.3 Global Concentration Ratios (CR8) for AI Drug Discovery Software in 2025
3.3 AI Drug Discovery Software Company Evaluation Quadrant
3.4 AI Drug Discovery Software Market: Overall Company Footprint Analysis
3.4.1 AI Drug Discovery Software Market: Region Footprint
3.4.2 AI Drug Discovery Software Market: Company Product Type Footprint
3.4.3 AI Drug Discovery Software Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers & Acquisitions Activity
4 UNITED STATES VS CHINA VS REST OF WORLD (BY HEADQUARTER LOCATION)
4.1 United States VS China: AI Drug Discovery Software Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: AI Drug Discovery Software Revenue Comparison (2021 & 2025 & 2032) (by Headquarter Location)
4.1.2 United States VS China: AI Drug Discovery Software Revenue Market Share Comparison (2021 & 2025 & 2032)
4.2 United States Based Companies VS China Based Companies: AI Drug Discovery Software Consumption Value Comparison
4.2.1 United States VS China: AI Drug Discovery Software Consumption Value Comparison (2021 & 2025 & 2032)
4.2.2 United States VS China: AI Drug Discovery Software Consumption Value Market Share Comparison (2021 & 2025 & 2032)
4.3 United States Based AI Drug Discovery Software Companies and Market Share, 2021-2026
4.3.1 United States Based AI Drug Discovery Software Companies, Headquarters (States, Country)
4.3.2 United States Based Companies AI Drug Discovery Software Revenue, (2021-2026)
4.4 China Based Companies AI Drug Discovery Software Revenue and Market Share, 2021-2026
4.4.1 China Based AI Drug Discovery Software Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies AI Drug Discovery Software Revenue, (2021-2026)
4.5 Rest of World Based AI Drug Discovery Software Companies and Market Share, 2021-2026
4.5.1 Rest of World Based AI Drug Discovery Software Companies, Headquarters (Province, Country)
4.5.2 Rest of World Based Companies AI Drug Discovery Software Revenue (2021-2026)
5 MARKET ANALYSIS BY TYPE
5.1 World AI Drug Discovery Software Market Size Overview by Type: 2021 VS 2025 VS 2032
5.2 Segment Introduction by Type
5.2.1 Cloud Based
5.2.2 On Premise
5.3 Market Segment by Type
5.3.1 World AI Drug Discovery Software Market Size by Type (2021-2026)
5.3.2 World AI Drug Discovery Software Market Size by Type (2027-2032)
5.3.3 World AI Drug Discovery Software Market Size Market Share by Type (2027-2032)
6 MARKET ANALYSIS BY DRUG DISCOVERY STAGE
6.1 World AI Drug Discovery Software Market Size Overview by Drug Discovery Stage: 2021 VS 2025 VS 2032
6.2 Segment Introduction by Drug Discovery Stage
6.2.1 Target Identification & Validation
6.2.2 Hit Discovery / Virtual Screening
6.2.3 Lead Optimization
6.2.4 ADMET & Toxicity Prediction
6.2.5 Candidate Selection & Preclinical Support
6.3 Market Segment by Drug Discovery Stage
6.3.1 World AI Drug Discovery Software Market Size by Drug Discovery Stage (2021-2026)
6.3.2 World AI Drug Discovery Software Market Size by Drug Discovery Stage (2027-2032)
6.3.3 World AI Drug Discovery Software Market Size Market Share by Drug Discovery Stage (2027-2032)
7 MARKET ANALYSIS BY AI TASK & FUNCTION
7.1 World AI Drug Discovery Software Market Size Overview by AI Task & Function: 2021 VS 2025 VS 2032
7.2 Segment Introduction by AI Task & Function
7.2.1 Molecular Property Prediction
7.2.2 De Novo Molecule Generation
7.2.3 Protein?Ligand Interaction Modeling
7.2.4 Multi-Parameter Optimization
7.2.5 Knowledge Graph?Based Discovery
7.3 Market Segment by AI Task & Function
7.3.1 World AI Drug Discovery Software Market Size by AI Task & Function (2021-2026)
7.3.2 World AI Drug Discovery Software Market Size by AI Task & Function (2027-2032)
7.3.3 World AI Drug Discovery Software Market Size Market Share by AI Task & Function (2027-2032)
8 MARKET ANALYSIS BY APPLICATION
8.1 World AI Drug Discovery Software Market Size Overview by Application: 2021 VS 2025 VS 2032
8.2 Segment Introduction by Application
8.2.1 CRO and Universities
8.2.2 Pharmaceutical Company
8.2.3 Test Lab
8.3 Market Segment by Application
8.3.1 World AI Drug Discovery Software Market Size by Application (2021-2026)
8.3.2 World AI Drug Discovery Software Market Size by Application (2027-2032)
8.3.3 World AI Drug Discovery Software Market Size Market Share by Application (2021-2032)
9 COMPANY PROFILES
9.1 Merck KGaA
9.1.1 Merck KGaA Details
9.1.2 Merck KGaA Major Business
9.1.3 Merck KGaA AI Drug Discovery Software Product and Services
9.1.4 Merck KGaA AI Drug Discovery Software Revenue, Gross Margin and Market Share (2021-2026)
9.1.5 Merck KGaA Recent Developments/Updates
9.1.6 Merck KGaA Competitive Strengths & Weaknesses
9.2 Atomwise Inc
9.2.1 Atomwise Inc Details
9.2.2 Atomwise Inc Major Business
9.2.3 Atomwise Inc AI Drug Discovery Software Product and Services
9.2.4 Atomwise Inc AI Drug Discovery Software Revenue, Gross Margin and Market Share (2021-2026)
9.2.5 Atomwise Inc Recent Developments/Updates
9.2.6 Atomwise Inc Competitive Strengths & Weaknesses
9.3 BenevolentAI
9.3.1 BenevolentAI Details
9.3.2 BenevolentAI Major Business
9.3.3 BenevolentAI AI Drug Discovery Software Product and Services
9.3.4 BenevolentAI AI Drug Discovery Software Revenue, Gross Margin and Market Share (2021-2026)
9.3.5 BenevolentAI Recent Developments/Updates
9.3.6 BenevolentAI Competitive Strengths & Weaknesses
9.4 BullFrog AI
9.4.1 BullFrog AI Details
9.4.2 BullFrog AI Major Business
9.4.3 BullFrog AI AI Drug Discovery Software Product and Services
9.4.4 BullFrog AI AI Drug Discovery Software Revenue, Gross Margin and Market Share (2021-2026)
9.4.5 BullFrog AI Recent Developments/Updates
9.4.6 BullFrog AI Competitive Strengths & Weaknesses
9.5 Genesis Therapeutics
9.5.1 Genesis Therapeutics Details
9.5.2 Genesis Therapeutics Major Business
9.5.3 Genesis Therapeutics AI Drug Discovery Software Product and Services
9.5.4 Genesis Therapeutics AI Drug Discovery Software Revenue, Gross Margin and Market Share (2021-2026)
9.5.5 Genesis Therapeutics Recent Developments/Updates
9.5.6 Genesis Therapeutics Competitive Strengths & Weaknesses
9.6 Pharma.AI
9.6.1 Pharma.AI Details
9.6.2 Pharma.AI Major Business
9.6.3 Pharma.AI AI Drug Discovery Software Product and Services
9.6.4 Pharma.AI AI Drug Discovery Software Revenue, Gross Margin and Market Share (2021-2026)
9.6.5 Pharma.AI Recent Developments/Updates
9.6.6 Pharma.AI Competitive Strengths & Weaknesses
9.7 Recursion Pharmaceuticals
9.7.1 Recursion Pharmaceuticals Details
9.7.2 Recursion Pharmaceuticals Major Business
9.7.3 Recursion Pharmaceuticals AI Drug Discovery Software Product and Services
9.7.4 Recursion Pharmaceuticals AI Drug Discovery Software Revenue, Gross Margin and Market Share (2021-2026)
9.7.5 Recursion Pharmaceuticals Recent Developments/Updates
9.7.6 Recursion Pharmaceuticals Competitive Strengths & Weaknesses
9.8 Verge Genomics
9.8.1 Verge Genomics Details
9.8.2 Verge Genomics Major Business
9.8.3 Verge Genomics AI Drug Discovery Software Product and Services
9.8.4 Verge Genomics AI Drug Discovery Software Revenue, Gross Margin and Market Share (2021-2026)
9.8.5 Verge Genomics Recent Developments/Updates
9.8.6 Verge Genomics Competitive Strengths & Weaknesses
9.9 Schr?dinger, Inc.
9.9.1 Schr?dinger, Inc. Details
9.9.2 Schr?dinger, Inc. Major Business
9.9.3 Schr?dinger, Inc. AI Drug Discovery Software Product and Services
9.9.4 Schr?dinger, Inc. AI Drug Discovery Software Revenue, Gross Margin and Market Share (2021-2026)
9.9.5 Schr?dinger, Inc. Recent Developments/Updates
9.9.6 Schr?dinger, Inc. Competitive Strengths & Weaknesses
9.10 XtalPi
9.10.1 XtalPi Details
9.10.2 XtalPi Major Business
9.10.3 XtalPi AI Drug Discovery Software Product and Services
9.10.4 XtalPi AI Drug Discovery Software Revenue, Gross Margin and Market Share (2021-2026)
9.10.5 XtalPi Recent Developments/Updates
9.10.6 XtalPi Competitive Strengths & Weaknesses
9.11 Iktos
9.11.1 Iktos Details
9.11.2 Iktos Major Business
9.11.3 Iktos AI Drug Discovery Software Product and Services
9.11.4 Iktos AI Drug Discovery Software Revenue, Gross Margin and Market Share (2021-2026)
9.11.5 Iktos Recent Developments/Updates
9.11.6 Iktos Competitive Strengths & Weaknesses
10 INDUSTRY CHAIN ANALYSIS
10.1 AI Drug Discovery Software Industry Chain
10.2 AI Drug Discovery Software Upstream Analysis
10.3 AI Drug Discovery Software Midstream Analysis
10.4 AI Drug Discovery Software Downstream Analysis
11 RESEARCH FINDINGS AND CONCLUSION
12 APPENDIX
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
1.1 AI Drug Discovery Software Introduction
1.2 World AI Drug Discovery Software Market Size & Forecast (2021 & 2025 & 2032)
1.3 World AI Drug Discovery Software Total Market by Region (by Headquarter Location)
1.3.1 World AI Drug Discovery Software Market Size by Region (2021-2032), (by Headquarter Location)
1.3.2 United States Based Company AI Drug Discovery Software Revenue (2021-2032)
1.3.3 China Based Company AI Drug Discovery Software Revenue (2021-2032)
1.3.4 Europe Based Company AI Drug Discovery Software Revenue (2021-2032)
1.3.5 Japan Based Company AI Drug Discovery Software Revenue (2021-2032)
1.3.6 South Korea Based Company AI Drug Discovery Software Revenue (2021-2032)
1.3.7 ASEAN Based Company AI Drug Discovery Software Revenue (2021-2032)
1.3.8 India Based Company AI Drug Discovery Software Revenue (2021-2032)
1.4 Market Drivers, Restraints and Trends
1.4.1 AI Drug Discovery Software Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Major Market Trends
2 DEMAND SUMMARY
2.1 World AI Drug Discovery Software Consumption Value (2021-2032)
2.2 World AI Drug Discovery Software Consumption Value by Region
2.2.1 World AI Drug Discovery Software Consumption Value by Region (2021-2026)
2.2.2 World AI Drug Discovery Software Consumption Value Forecast by Region (2027-2032)
2.3 United States AI Drug Discovery Software Consumption Value (2021-2032)
2.4 China AI Drug Discovery Software Consumption Value (2021-2032)
2.5 Europe AI Drug Discovery Software Consumption Value (2021-2032)
2.6 Japan AI Drug Discovery Software Consumption Value (2021-2032)
2.7 South Korea AI Drug Discovery Software Consumption Value (2021-2032)
2.8 ASEAN AI Drug Discovery Software Consumption Value (2021-2032)
2.9 India AI Drug Discovery Software Consumption Value (2021-2032)
3 WORLD AI DRUG DISCOVERY SOFTWARE COMPANIES COMPETITIVE ANALYSIS
3.1 World AI Drug Discovery Software Revenue by Player (2021-2026)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global AI Drug Discovery Software Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for AI Drug Discovery Software in 2025
3.2.3 Global Concentration Ratios (CR8) for AI Drug Discovery Software in 2025
3.3 AI Drug Discovery Software Company Evaluation Quadrant
3.4 AI Drug Discovery Software Market: Overall Company Footprint Analysis
3.4.1 AI Drug Discovery Software Market: Region Footprint
3.4.2 AI Drug Discovery Software Market: Company Product Type Footprint
3.4.3 AI Drug Discovery Software Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers & Acquisitions Activity
4 UNITED STATES VS CHINA VS REST OF WORLD (BY HEADQUARTER LOCATION)
4.1 United States VS China: AI Drug Discovery Software Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: AI Drug Discovery Software Revenue Comparison (2021 & 2025 & 2032) (by Headquarter Location)
4.1.2 United States VS China: AI Drug Discovery Software Revenue Market Share Comparison (2021 & 2025 & 2032)
4.2 United States Based Companies VS China Based Companies: AI Drug Discovery Software Consumption Value Comparison
4.2.1 United States VS China: AI Drug Discovery Software Consumption Value Comparison (2021 & 2025 & 2032)
4.2.2 United States VS China: AI Drug Discovery Software Consumption Value Market Share Comparison (2021 & 2025 & 2032)
4.3 United States Based AI Drug Discovery Software Companies and Market Share, 2021-2026
4.3.1 United States Based AI Drug Discovery Software Companies, Headquarters (States, Country)
4.3.2 United States Based Companies AI Drug Discovery Software Revenue, (2021-2026)
4.4 China Based Companies AI Drug Discovery Software Revenue and Market Share, 2021-2026
4.4.1 China Based AI Drug Discovery Software Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies AI Drug Discovery Software Revenue, (2021-2026)
4.5 Rest of World Based AI Drug Discovery Software Companies and Market Share, 2021-2026
4.5.1 Rest of World Based AI Drug Discovery Software Companies, Headquarters (Province, Country)
4.5.2 Rest of World Based Companies AI Drug Discovery Software Revenue (2021-2026)
5 MARKET ANALYSIS BY TYPE
5.1 World AI Drug Discovery Software Market Size Overview by Type: 2021 VS 2025 VS 2032
5.2 Segment Introduction by Type
5.2.1 Cloud Based
5.2.2 On Premise
5.3 Market Segment by Type
5.3.1 World AI Drug Discovery Software Market Size by Type (2021-2026)
5.3.2 World AI Drug Discovery Software Market Size by Type (2027-2032)
5.3.3 World AI Drug Discovery Software Market Size Market Share by Type (2027-2032)
6 MARKET ANALYSIS BY DRUG DISCOVERY STAGE
6.1 World AI Drug Discovery Software Market Size Overview by Drug Discovery Stage: 2021 VS 2025 VS 2032
6.2 Segment Introduction by Drug Discovery Stage
6.2.1 Target Identification & Validation
6.2.2 Hit Discovery / Virtual Screening
6.2.3 Lead Optimization
6.2.4 ADMET & Toxicity Prediction
6.2.5 Candidate Selection & Preclinical Support
6.3 Market Segment by Drug Discovery Stage
6.3.1 World AI Drug Discovery Software Market Size by Drug Discovery Stage (2021-2026)
6.3.2 World AI Drug Discovery Software Market Size by Drug Discovery Stage (2027-2032)
6.3.3 World AI Drug Discovery Software Market Size Market Share by Drug Discovery Stage (2027-2032)
7 MARKET ANALYSIS BY AI TASK & FUNCTION
7.1 World AI Drug Discovery Software Market Size Overview by AI Task & Function: 2021 VS 2025 VS 2032
7.2 Segment Introduction by AI Task & Function
7.2.1 Molecular Property Prediction
7.2.2 De Novo Molecule Generation
7.2.3 Protein?Ligand Interaction Modeling
7.2.4 Multi-Parameter Optimization
7.2.5 Knowledge Graph?Based Discovery
7.3 Market Segment by AI Task & Function
7.3.1 World AI Drug Discovery Software Market Size by AI Task & Function (2021-2026)
7.3.2 World AI Drug Discovery Software Market Size by AI Task & Function (2027-2032)
7.3.3 World AI Drug Discovery Software Market Size Market Share by AI Task & Function (2027-2032)
8 MARKET ANALYSIS BY APPLICATION
8.1 World AI Drug Discovery Software Market Size Overview by Application: 2021 VS 2025 VS 2032
8.2 Segment Introduction by Application
8.2.1 CRO and Universities
8.2.2 Pharmaceutical Company
8.2.3 Test Lab
8.3 Market Segment by Application
8.3.1 World AI Drug Discovery Software Market Size by Application (2021-2026)
8.3.2 World AI Drug Discovery Software Market Size by Application (2027-2032)
8.3.3 World AI Drug Discovery Software Market Size Market Share by Application (2021-2032)
9 COMPANY PROFILES
9.1 Merck KGaA
9.1.1 Merck KGaA Details
9.1.2 Merck KGaA Major Business
9.1.3 Merck KGaA AI Drug Discovery Software Product and Services
9.1.4 Merck KGaA AI Drug Discovery Software Revenue, Gross Margin and Market Share (2021-2026)
9.1.5 Merck KGaA Recent Developments/Updates
9.1.6 Merck KGaA Competitive Strengths & Weaknesses
9.2 Atomwise Inc
9.2.1 Atomwise Inc Details
9.2.2 Atomwise Inc Major Business
9.2.3 Atomwise Inc AI Drug Discovery Software Product and Services
9.2.4 Atomwise Inc AI Drug Discovery Software Revenue, Gross Margin and Market Share (2021-2026)
9.2.5 Atomwise Inc Recent Developments/Updates
9.2.6 Atomwise Inc Competitive Strengths & Weaknesses
9.3 BenevolentAI
9.3.1 BenevolentAI Details
9.3.2 BenevolentAI Major Business
9.3.3 BenevolentAI AI Drug Discovery Software Product and Services
9.3.4 BenevolentAI AI Drug Discovery Software Revenue, Gross Margin and Market Share (2021-2026)
9.3.5 BenevolentAI Recent Developments/Updates
9.3.6 BenevolentAI Competitive Strengths & Weaknesses
9.4 BullFrog AI
9.4.1 BullFrog AI Details
9.4.2 BullFrog AI Major Business
9.4.3 BullFrog AI AI Drug Discovery Software Product and Services
9.4.4 BullFrog AI AI Drug Discovery Software Revenue, Gross Margin and Market Share (2021-2026)
9.4.5 BullFrog AI Recent Developments/Updates
9.4.6 BullFrog AI Competitive Strengths & Weaknesses
9.5 Genesis Therapeutics
9.5.1 Genesis Therapeutics Details
9.5.2 Genesis Therapeutics Major Business
9.5.3 Genesis Therapeutics AI Drug Discovery Software Product and Services
9.5.4 Genesis Therapeutics AI Drug Discovery Software Revenue, Gross Margin and Market Share (2021-2026)
9.5.5 Genesis Therapeutics Recent Developments/Updates
9.5.6 Genesis Therapeutics Competitive Strengths & Weaknesses
9.6 Pharma.AI
9.6.1 Pharma.AI Details
9.6.2 Pharma.AI Major Business
9.6.3 Pharma.AI AI Drug Discovery Software Product and Services
9.6.4 Pharma.AI AI Drug Discovery Software Revenue, Gross Margin and Market Share (2021-2026)
9.6.5 Pharma.AI Recent Developments/Updates
9.6.6 Pharma.AI Competitive Strengths & Weaknesses
9.7 Recursion Pharmaceuticals
9.7.1 Recursion Pharmaceuticals Details
9.7.2 Recursion Pharmaceuticals Major Business
9.7.3 Recursion Pharmaceuticals AI Drug Discovery Software Product and Services
9.7.4 Recursion Pharmaceuticals AI Drug Discovery Software Revenue, Gross Margin and Market Share (2021-2026)
9.7.5 Recursion Pharmaceuticals Recent Developments/Updates
9.7.6 Recursion Pharmaceuticals Competitive Strengths & Weaknesses
9.8 Verge Genomics
9.8.1 Verge Genomics Details
9.8.2 Verge Genomics Major Business
9.8.3 Verge Genomics AI Drug Discovery Software Product and Services
9.8.4 Verge Genomics AI Drug Discovery Software Revenue, Gross Margin and Market Share (2021-2026)
9.8.5 Verge Genomics Recent Developments/Updates
9.8.6 Verge Genomics Competitive Strengths & Weaknesses
9.9 Schr?dinger, Inc.
9.9.1 Schr?dinger, Inc. Details
9.9.2 Schr?dinger, Inc. Major Business
9.9.3 Schr?dinger, Inc. AI Drug Discovery Software Product and Services
9.9.4 Schr?dinger, Inc. AI Drug Discovery Software Revenue, Gross Margin and Market Share (2021-2026)
9.9.5 Schr?dinger, Inc. Recent Developments/Updates
9.9.6 Schr?dinger, Inc. Competitive Strengths & Weaknesses
9.10 XtalPi
9.10.1 XtalPi Details
9.10.2 XtalPi Major Business
9.10.3 XtalPi AI Drug Discovery Software Product and Services
9.10.4 XtalPi AI Drug Discovery Software Revenue, Gross Margin and Market Share (2021-2026)
9.10.5 XtalPi Recent Developments/Updates
9.10.6 XtalPi Competitive Strengths & Weaknesses
9.11 Iktos
9.11.1 Iktos Details
9.11.2 Iktos Major Business
9.11.3 Iktos AI Drug Discovery Software Product and Services
9.11.4 Iktos AI Drug Discovery Software Revenue, Gross Margin and Market Share (2021-2026)
9.11.5 Iktos Recent Developments/Updates
9.11.6 Iktos Competitive Strengths & Weaknesses
10 INDUSTRY CHAIN ANALYSIS
10.1 AI Drug Discovery Software Industry Chain
10.2 AI Drug Discovery Software Upstream Analysis
10.3 AI Drug Discovery Software Midstream Analysis
10.4 AI Drug Discovery Software Downstream Analysis
11 RESEARCH FINDINGS AND CONCLUSION
12 APPENDIX
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
LIST OF TABLES
Table 1. World AI Drug Discovery Software Revenue by Region (2021, 2025 and 2032) & (USD Million), (by Headquarter Location)
Table 2. World AI Drug Discovery Software Revenue by Region (2021-2026) & (USD Million), (by Headquarter Location)
Table 3. World AI Drug Discovery Software Revenue by Region (2027-2032) & (USD Million), (by Headquarter Location)
Table 4. World AI Drug Discovery Software Revenue Market Share by Region (2021-2026), (by Headquarter Location)
Table 5. World AI Drug Discovery Software Revenue Market Share by Region (2027-2032), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World AI Drug Discovery Software Consumption Value Growth Rate Forecast by Region (2021 & 2025 & 2032) & (USD Million)
Table 8. World AI Drug Discovery Software Consumption Value by Region (2021-2026) & (USD Million)
Table 9. World AI Drug Discovery Software Consumption Value Forecast by Region (2027-2032) & (USD Million)
Table 10. World AI Drug Discovery Software Revenue by Player (2021-2026) & (USD Million)
Table 11. Revenue Market Share of Key AI Drug Discovery Software Players in 2025
Table 12. World AI Drug Discovery Software Industry Rank of Major Player, Based on Revenue in 2025
Table 13. Global AI Drug Discovery Software Company Evaluation Quadrant
Table 14. Head Office of Key AI Drug Discovery Software Players
Table 15. AI Drug Discovery Software Market: Company Product Type Footprint
Table 16. AI Drug Discovery Software Market: Company Product Application Footprint
Table 17. AI Drug Discovery Software Mergers & Acquisitions Activity
Table 18. United States VS China AI Drug Discovery Software Revenue Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 19. United States VS China AI Drug Discovery Software Consumption Value Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 20. United States Based AI Drug Discovery Software Companies, Headquarters (States, Country)
Table 21. United States Based Companies AI Drug Discovery Software Revenue, (2021-2026) & (USD Million)
Table 22. United States Based Companies AI Drug Discovery Software Revenue Market Share (2021-2026)
Table 23. China Based AI Drug Discovery Software Companies, Headquarters (Province, Country)
Table 24. China Based Companies AI Drug Discovery Software Revenue, (2021-2026) & (USD Million)
Table 25. China Based Companies AI Drug Discovery Software Revenue Market Share (2021-2026)
Table 26. Rest of World Based AI Drug Discovery Software Companies, Headquarters (Province, Country)
Table 27. Rest of World Based Companies AI Drug Discovery Software Revenue (2021-2026) & (USD Million)
Table 28. Rest of World Based Companies AI Drug Discovery Software Revenue Market Share (2021-2026)
Table 29. World AI Drug Discovery Software Market Size by Type, (USD Million), 2021 & 2025 & 2032
Table 30. World AI Drug Discovery Software Market Size Value by Type (2021-2026) & (USD Million)
Table 31. World AI Drug Discovery Software Market Size by Type (2027-2032) & (USD Million)
Table 32. World AI Drug Discovery Software Market Size by Drug Discovery Stage, (USD Million), 2021 & 2025 & 2032
Table 33. World AI Drug Discovery Software Market Size Value by Drug Discovery Stage (2021-2026) & (USD Million)
Table 34. World AI Drug Discovery Software Market Size by Drug Discovery Stage (2027-2032) & (USD Million)
Table 35. World AI Drug Discovery Software Market Size by AI Task & Function, (USD Million), 2021 & 2025 & 2032
Table 36. World AI Drug Discovery Software Market Size Value by AI Task & Function (2021-2026) & (USD Million)
Table 37. World AI Drug Discovery Software Market Size by AI Task & Function (2027-2032) & (USD Million)
Table 38. World AI Drug Discovery Software Market Size by Application, (USD Million), 2021 & 2025 & 2032
Table 39. World AI Drug Discovery Software Market Size by Application (2021-2026) & (USD Million)
Table 40. World AI Drug Discovery Software Market Size by Application (2027-2032) & (USD Million)
Table 41. Merck KGaA Basic Information, Manufacturing Base and Competitors
Table 42. Merck KGaA Major Business
Table 43. Merck KGaA AI Drug Discovery Software Product and Services
Table 44. Merck KGaA AI Drug Discovery Software Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 45. Merck KGaA Recent Developments/Updates
Table 46. Merck KGaA Competitive Strengths & Weaknesses
Table 47. Atomwise Inc Basic Information, Manufacturing Base and Competitors
Table 48. Atomwise Inc Major Business
Table 49. Atomwise Inc AI Drug Discovery Software Product and Services
Table 50. Atomwise Inc AI Drug Discovery Software Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 51. Atomwise Inc Recent Developments/Updates
Table 52. Atomwise Inc Competitive Strengths & Weaknesses
Table 53. BenevolentAI Basic Information, Manufacturing Base and Competitors
Table 54. BenevolentAI Major Business
Table 55. BenevolentAI AI Drug Discovery Software Product and Services
Table 56. BenevolentAI AI Drug Discovery Software Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 57. BenevolentAI Recent Developments/Updates
Table 58. BenevolentAI Competitive Strengths & Weaknesses
Table 59. BullFrog AI Basic Information, Manufacturing Base and Competitors
Table 60. BullFrog AI Major Business
Table 61. BullFrog AI AI Drug Discovery Software Product and Services
Table 62. BullFrog AI AI Drug Discovery Software Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 63. BullFrog AI Recent Developments/Updates
Table 64. BullFrog AI Competitive Strengths & Weaknesses
Table 65. Genesis Therapeutics Basic Information, Manufacturing Base and Competitors
Table 66. Genesis Therapeutics Major Business
Table 67. Genesis Therapeutics AI Drug Discovery Software Product and Services
Table 68. Genesis Therapeutics AI Drug Discovery Software Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 69. Genesis Therapeutics Recent Developments/Updates
Table 70. Genesis Therapeutics Competitive Strengths & Weaknesses
Table 71. Pharma.AI Basic Information, Manufacturing Base and Competitors
Table 72. Pharma.AI Major Business
Table 73. Pharma.AI AI Drug Discovery Software Product and Services
Table 74. Pharma.AI AI Drug Discovery Software Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 75. Pharma.AI Recent Developments/Updates
Table 76. Pharma.AI Competitive Strengths & Weaknesses
Table 77. Recursion Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 78. Recursion Pharmaceuticals Major Business
Table 79. Recursion Pharmaceuticals AI Drug Discovery Software Product and Services
Table 80. Recursion Pharmaceuticals AI Drug Discovery Software Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 81. Recursion Pharmaceuticals Recent Developments/Updates
Table 82. Recursion Pharmaceuticals Competitive Strengths & Weaknesses
Table 83. Verge Genomics Basic Information, Manufacturing Base and Competitors
Table 84. Verge Genomics Major Business
Table 85. Verge Genomics AI Drug Discovery Software Product and Services
Table 86. Verge Genomics AI Drug Discovery Software Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 87. Verge Genomics Recent Developments/Updates
Table 88. Verge Genomics Competitive Strengths & Weaknesses
Table 89. Schr?dinger, Inc. Basic Information, Manufacturing Base and Competitors
Table 90. Schr?dinger, Inc. Major Business
Table 91. Schr?dinger, Inc. AI Drug Discovery Software Product and Services
Table 92. Schr?dinger, Inc. AI Drug Discovery Software Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 93. Schr?dinger, Inc. Recent Developments/Updates
Table 94. Schr?dinger, Inc. Competitive Strengths & Weaknesses
Table 95. XtalPi Basic Information, Manufacturing Base and Competitors
Table 96. XtalPi Major Business
Table 97. XtalPi AI Drug Discovery Software Product and Services
Table 98. XtalPi AI Drug Discovery Software Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 99. XtalPi Recent Developments/Updates
Table 100. XtalPi Competitive Strengths & Weaknesses
Table 101. Iktos Basic Information, Manufacturing Base and Competitors
Table 102. Iktos Major Business
Table 103. Iktos AI Drug Discovery Software Product and Services
Table 104. Iktos AI Drug Discovery Software Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 105. Iktos Recent Developments/Updates
Table 106. Iktos Competitive Strengths & Weaknesses
Table 107. Global Key Players of AI Drug Discovery Software Upstream (Raw Materials)
Table 108. Global AI Drug Discovery Software Typical Customers
Table 1. World AI Drug Discovery Software Revenue by Region (2021, 2025 and 2032) & (USD Million), (by Headquarter Location)
Table 2. World AI Drug Discovery Software Revenue by Region (2021-2026) & (USD Million), (by Headquarter Location)
Table 3. World AI Drug Discovery Software Revenue by Region (2027-2032) & (USD Million), (by Headquarter Location)
Table 4. World AI Drug Discovery Software Revenue Market Share by Region (2021-2026), (by Headquarter Location)
Table 5. World AI Drug Discovery Software Revenue Market Share by Region (2027-2032), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World AI Drug Discovery Software Consumption Value Growth Rate Forecast by Region (2021 & 2025 & 2032) & (USD Million)
Table 8. World AI Drug Discovery Software Consumption Value by Region (2021-2026) & (USD Million)
Table 9. World AI Drug Discovery Software Consumption Value Forecast by Region (2027-2032) & (USD Million)
Table 10. World AI Drug Discovery Software Revenue by Player (2021-2026) & (USD Million)
Table 11. Revenue Market Share of Key AI Drug Discovery Software Players in 2025
Table 12. World AI Drug Discovery Software Industry Rank of Major Player, Based on Revenue in 2025
Table 13. Global AI Drug Discovery Software Company Evaluation Quadrant
Table 14. Head Office of Key AI Drug Discovery Software Players
Table 15. AI Drug Discovery Software Market: Company Product Type Footprint
Table 16. AI Drug Discovery Software Market: Company Product Application Footprint
Table 17. AI Drug Discovery Software Mergers & Acquisitions Activity
Table 18. United States VS China AI Drug Discovery Software Revenue Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 19. United States VS China AI Drug Discovery Software Consumption Value Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 20. United States Based AI Drug Discovery Software Companies, Headquarters (States, Country)
Table 21. United States Based Companies AI Drug Discovery Software Revenue, (2021-2026) & (USD Million)
Table 22. United States Based Companies AI Drug Discovery Software Revenue Market Share (2021-2026)
Table 23. China Based AI Drug Discovery Software Companies, Headquarters (Province, Country)
Table 24. China Based Companies AI Drug Discovery Software Revenue, (2021-2026) & (USD Million)
Table 25. China Based Companies AI Drug Discovery Software Revenue Market Share (2021-2026)
Table 26. Rest of World Based AI Drug Discovery Software Companies, Headquarters (Province, Country)
Table 27. Rest of World Based Companies AI Drug Discovery Software Revenue (2021-2026) & (USD Million)
Table 28. Rest of World Based Companies AI Drug Discovery Software Revenue Market Share (2021-2026)
Table 29. World AI Drug Discovery Software Market Size by Type, (USD Million), 2021 & 2025 & 2032
Table 30. World AI Drug Discovery Software Market Size Value by Type (2021-2026) & (USD Million)
Table 31. World AI Drug Discovery Software Market Size by Type (2027-2032) & (USD Million)
Table 32. World AI Drug Discovery Software Market Size by Drug Discovery Stage, (USD Million), 2021 & 2025 & 2032
Table 33. World AI Drug Discovery Software Market Size Value by Drug Discovery Stage (2021-2026) & (USD Million)
Table 34. World AI Drug Discovery Software Market Size by Drug Discovery Stage (2027-2032) & (USD Million)
Table 35. World AI Drug Discovery Software Market Size by AI Task & Function, (USD Million), 2021 & 2025 & 2032
Table 36. World AI Drug Discovery Software Market Size Value by AI Task & Function (2021-2026) & (USD Million)
Table 37. World AI Drug Discovery Software Market Size by AI Task & Function (2027-2032) & (USD Million)
Table 38. World AI Drug Discovery Software Market Size by Application, (USD Million), 2021 & 2025 & 2032
Table 39. World AI Drug Discovery Software Market Size by Application (2021-2026) & (USD Million)
Table 40. World AI Drug Discovery Software Market Size by Application (2027-2032) & (USD Million)
Table 41. Merck KGaA Basic Information, Manufacturing Base and Competitors
Table 42. Merck KGaA Major Business
Table 43. Merck KGaA AI Drug Discovery Software Product and Services
Table 44. Merck KGaA AI Drug Discovery Software Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 45. Merck KGaA Recent Developments/Updates
Table 46. Merck KGaA Competitive Strengths & Weaknesses
Table 47. Atomwise Inc Basic Information, Manufacturing Base and Competitors
Table 48. Atomwise Inc Major Business
Table 49. Atomwise Inc AI Drug Discovery Software Product and Services
Table 50. Atomwise Inc AI Drug Discovery Software Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 51. Atomwise Inc Recent Developments/Updates
Table 52. Atomwise Inc Competitive Strengths & Weaknesses
Table 53. BenevolentAI Basic Information, Manufacturing Base and Competitors
Table 54. BenevolentAI Major Business
Table 55. BenevolentAI AI Drug Discovery Software Product and Services
Table 56. BenevolentAI AI Drug Discovery Software Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 57. BenevolentAI Recent Developments/Updates
Table 58. BenevolentAI Competitive Strengths & Weaknesses
Table 59. BullFrog AI Basic Information, Manufacturing Base and Competitors
Table 60. BullFrog AI Major Business
Table 61. BullFrog AI AI Drug Discovery Software Product and Services
Table 62. BullFrog AI AI Drug Discovery Software Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 63. BullFrog AI Recent Developments/Updates
Table 64. BullFrog AI Competitive Strengths & Weaknesses
Table 65. Genesis Therapeutics Basic Information, Manufacturing Base and Competitors
Table 66. Genesis Therapeutics Major Business
Table 67. Genesis Therapeutics AI Drug Discovery Software Product and Services
Table 68. Genesis Therapeutics AI Drug Discovery Software Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 69. Genesis Therapeutics Recent Developments/Updates
Table 70. Genesis Therapeutics Competitive Strengths & Weaknesses
Table 71. Pharma.AI Basic Information, Manufacturing Base and Competitors
Table 72. Pharma.AI Major Business
Table 73. Pharma.AI AI Drug Discovery Software Product and Services
Table 74. Pharma.AI AI Drug Discovery Software Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 75. Pharma.AI Recent Developments/Updates
Table 76. Pharma.AI Competitive Strengths & Weaknesses
Table 77. Recursion Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 78. Recursion Pharmaceuticals Major Business
Table 79. Recursion Pharmaceuticals AI Drug Discovery Software Product and Services
Table 80. Recursion Pharmaceuticals AI Drug Discovery Software Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 81. Recursion Pharmaceuticals Recent Developments/Updates
Table 82. Recursion Pharmaceuticals Competitive Strengths & Weaknesses
Table 83. Verge Genomics Basic Information, Manufacturing Base and Competitors
Table 84. Verge Genomics Major Business
Table 85. Verge Genomics AI Drug Discovery Software Product and Services
Table 86. Verge Genomics AI Drug Discovery Software Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 87. Verge Genomics Recent Developments/Updates
Table 88. Verge Genomics Competitive Strengths & Weaknesses
Table 89. Schr?dinger, Inc. Basic Information, Manufacturing Base and Competitors
Table 90. Schr?dinger, Inc. Major Business
Table 91. Schr?dinger, Inc. AI Drug Discovery Software Product and Services
Table 92. Schr?dinger, Inc. AI Drug Discovery Software Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 93. Schr?dinger, Inc. Recent Developments/Updates
Table 94. Schr?dinger, Inc. Competitive Strengths & Weaknesses
Table 95. XtalPi Basic Information, Manufacturing Base and Competitors
Table 96. XtalPi Major Business
Table 97. XtalPi AI Drug Discovery Software Product and Services
Table 98. XtalPi AI Drug Discovery Software Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 99. XtalPi Recent Developments/Updates
Table 100. XtalPi Competitive Strengths & Weaknesses
Table 101. Iktos Basic Information, Manufacturing Base and Competitors
Table 102. Iktos Major Business
Table 103. Iktos AI Drug Discovery Software Product and Services
Table 104. Iktos AI Drug Discovery Software Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 105. Iktos Recent Developments/Updates
Table 106. Iktos Competitive Strengths & Weaknesses
Table 107. Global Key Players of AI Drug Discovery Software Upstream (Raw Materials)
Table 108. Global AI Drug Discovery Software Typical Customers
LIST OF FIGURES
Figure 1. AI Drug Discovery Software Picture
Figure 2. World AI Drug Discovery Software Total Revenue: 2021 & 2025 & 2032, (USD Million)
Figure 3. World AI Drug Discovery Software Total Revenue (2021-2032) & (USD Million)
Figure 4. World AI Drug Discovery Software Revenue by Region (2021, 2025 and 2032) & (USD Million), (by Headquarter Location)
Figure 5. World AI Drug Discovery Software Revenue Market Share by Region (2021-2032), (by Headquarter Location)
Figure 6. United States Based Company AI Drug Discovery Software Revenue (2021-2032) & (USD Million)
Figure 7. China Based Company AI Drug Discovery Software Revenue (2021-2032) & (USD Million)
Figure 8. Europe Based Company AI Drug Discovery Software Revenue (2021-2032) & (USD Million)
Figure 9. Japan Based Company AI Drug Discovery Software Revenue (2021-2032) & (USD Million)
Figure 10. South Korea Based Company AI Drug Discovery Software Revenue (2021-2032) & (USD Million)
Figure 11. ASEAN Based Company AI Drug Discovery Software Revenue (2021-2032) & (USD Million)
Figure 12. India Based Company AI Drug Discovery Software Revenue (2021-2032) & (USD Million)
Figure 13. AI Drug Discovery Software Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World AI Drug Discovery Software Consumption Value (2021-2032) & (USD Million)
Figure 16. World AI Drug Discovery Software Consumption Value Market Share by Region (2021-2032)
Figure 17. United States AI Drug Discovery Software Consumption Value (2021-2032) & (USD Million)
Figure 18. China AI Drug Discovery Software Consumption Value (2021-2032) & (USD Million)
Figure 19. Europe AI Drug Discovery Software Consumption Value (2021-2032) & (USD Million)
Figure 20. Japan AI Drug Discovery Software Consumption Value (2021-2032) & (USD Million)
Figure 21. South Korea AI Drug Discovery Software Consumption Value (2021-2032) & (USD Million)
Figure 22. ASEAN AI Drug Discovery Software Consumption Value (2021-2032) & (USD Million)
Figure 23. India AI Drug Discovery Software Consumption Value (2021-2032) & (USD Million)
Figure 24. Producer Shipments of AI Drug Discovery Software by Player Revenue ($MM) and Market Share (%): 2025
Figure 25. Global Four-firm Concentration Ratios (CR4) for AI Drug Discovery Software Markets in 2025
Figure 26. Global Four-firm Concentration Ratios (CR8) for AI Drug Discovery Software Markets in 2025
Figure 27. United States VS China: AI Drug Discovery Software Revenue Market Share Comparison (2021 & 2025 & 2032)
Figure 28. United States VS China: AI Drug Discovery Software Consumption Value Market Share Comparison (2021 & 2025 & 2032)
Figure 29. World AI Drug Discovery Software Market Size by Type, (USD Million), 2021 & 2025 & 2032
Figure 30. World AI Drug Discovery Software Market Size Market Share by Type in 2025
Figure 31. Cloud Based
Figure 32. On Premise
Figure 33. World AI Drug Discovery Software Market Size Market Share by Type (2021-2032)
Figure 34. World AI Drug Discovery Software Market Size by Drug Discovery Stage, (USD Million), 2021 & 2025 & 2032
Figure 35. World AI Drug Discovery Software Market Size Market Share by Drug Discovery Stage in 2025
Figure 36. Target Identification & Validation
Figure 37. Hit Discovery / Virtual Screening
Figure 38. Lead Optimization
Figure 39. ADMET & Toxicity Prediction
Figure 40. Candidate Selection & Preclinical Support
Figure 41. World AI Drug Discovery Software Market Size Market Share by Drug Discovery Stage (2021-2032)
Figure 42. World AI Drug Discovery Software Market Size by AI Task & Function, (USD Million), 2021 & 2025 & 2032
Figure 43. World AI Drug Discovery Software Market Size Market Share by AI Task & Function in 2025
Figure 44. Molecular Property Prediction
Figure 45. De Novo Molecule Generation
Figure 46. Protein?Ligand Interaction Modeling
Figure 47. Multi-Parameter Optimization
Figure 48. Knowledge Graph?Based Discovery
Figure 49. World AI Drug Discovery Software Market Size Market Share by AI Task & Function (2021-2032)
Figure 50. World AI Drug Discovery Software Market Size by Application, (USD Million), 2021 & 2025 & 2032
Figure 51. World AI Drug Discovery Software Market Size Market Share by Application in 2025
Figure 52. CRO and Universities
Figure 53. Pharmaceutical Company
Figure 54. Test Lab
Figure 55. World AI Drug Discovery Software Market Size Market Share by Application (2021-2032)
Figure 56. AI Drug Discovery Software Industrial Chain
Figure 57. Methodology
Figure 58. Research Process and Data Source
Figure 1. AI Drug Discovery Software Picture
Figure 2. World AI Drug Discovery Software Total Revenue: 2021 & 2025 & 2032, (USD Million)
Figure 3. World AI Drug Discovery Software Total Revenue (2021-2032) & (USD Million)
Figure 4. World AI Drug Discovery Software Revenue by Region (2021, 2025 and 2032) & (USD Million), (by Headquarter Location)
Figure 5. World AI Drug Discovery Software Revenue Market Share by Region (2021-2032), (by Headquarter Location)
Figure 6. United States Based Company AI Drug Discovery Software Revenue (2021-2032) & (USD Million)
Figure 7. China Based Company AI Drug Discovery Software Revenue (2021-2032) & (USD Million)
Figure 8. Europe Based Company AI Drug Discovery Software Revenue (2021-2032) & (USD Million)
Figure 9. Japan Based Company AI Drug Discovery Software Revenue (2021-2032) & (USD Million)
Figure 10. South Korea Based Company AI Drug Discovery Software Revenue (2021-2032) & (USD Million)
Figure 11. ASEAN Based Company AI Drug Discovery Software Revenue (2021-2032) & (USD Million)
Figure 12. India Based Company AI Drug Discovery Software Revenue (2021-2032) & (USD Million)
Figure 13. AI Drug Discovery Software Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World AI Drug Discovery Software Consumption Value (2021-2032) & (USD Million)
Figure 16. World AI Drug Discovery Software Consumption Value Market Share by Region (2021-2032)
Figure 17. United States AI Drug Discovery Software Consumption Value (2021-2032) & (USD Million)
Figure 18. China AI Drug Discovery Software Consumption Value (2021-2032) & (USD Million)
Figure 19. Europe AI Drug Discovery Software Consumption Value (2021-2032) & (USD Million)
Figure 20. Japan AI Drug Discovery Software Consumption Value (2021-2032) & (USD Million)
Figure 21. South Korea AI Drug Discovery Software Consumption Value (2021-2032) & (USD Million)
Figure 22. ASEAN AI Drug Discovery Software Consumption Value (2021-2032) & (USD Million)
Figure 23. India AI Drug Discovery Software Consumption Value (2021-2032) & (USD Million)
Figure 24. Producer Shipments of AI Drug Discovery Software by Player Revenue ($MM) and Market Share (%): 2025
Figure 25. Global Four-firm Concentration Ratios (CR4) for AI Drug Discovery Software Markets in 2025
Figure 26. Global Four-firm Concentration Ratios (CR8) for AI Drug Discovery Software Markets in 2025
Figure 27. United States VS China: AI Drug Discovery Software Revenue Market Share Comparison (2021 & 2025 & 2032)
Figure 28. United States VS China: AI Drug Discovery Software Consumption Value Market Share Comparison (2021 & 2025 & 2032)
Figure 29. World AI Drug Discovery Software Market Size by Type, (USD Million), 2021 & 2025 & 2032
Figure 30. World AI Drug Discovery Software Market Size Market Share by Type in 2025
Figure 31. Cloud Based
Figure 32. On Premise
Figure 33. World AI Drug Discovery Software Market Size Market Share by Type (2021-2032)
Figure 34. World AI Drug Discovery Software Market Size by Drug Discovery Stage, (USD Million), 2021 & 2025 & 2032
Figure 35. World AI Drug Discovery Software Market Size Market Share by Drug Discovery Stage in 2025
Figure 36. Target Identification & Validation
Figure 37. Hit Discovery / Virtual Screening
Figure 38. Lead Optimization
Figure 39. ADMET & Toxicity Prediction
Figure 40. Candidate Selection & Preclinical Support
Figure 41. World AI Drug Discovery Software Market Size Market Share by Drug Discovery Stage (2021-2032)
Figure 42. World AI Drug Discovery Software Market Size by AI Task & Function, (USD Million), 2021 & 2025 & 2032
Figure 43. World AI Drug Discovery Software Market Size Market Share by AI Task & Function in 2025
Figure 44. Molecular Property Prediction
Figure 45. De Novo Molecule Generation
Figure 46. Protein?Ligand Interaction Modeling
Figure 47. Multi-Parameter Optimization
Figure 48. Knowledge Graph?Based Discovery
Figure 49. World AI Drug Discovery Software Market Size Market Share by AI Task & Function (2021-2032)
Figure 50. World AI Drug Discovery Software Market Size by Application, (USD Million), 2021 & 2025 & 2032
Figure 51. World AI Drug Discovery Software Market Size Market Share by Application in 2025
Figure 52. CRO and Universities
Figure 53. Pharmaceutical Company
Figure 54. Test Lab
Figure 55. World AI Drug Discovery Software Market Size Market Share by Application (2021-2032)
Figure 56. AI Drug Discovery Software Industrial Chain
Figure 57. Methodology
Figure 58. Research Process and Data Source
